<SEC-DOCUMENT>0001213900-21-002942-index.html : 20210120 <SEC-HEADER>0001213900-21-002942.hdr.sgml : 20210120 <ACCEPTANCE-DATETIME>20210119173326 ACCESSION NUMBER: 0001213900-21-002942 CONFORMED SUBMISSION TYPE: F-1/A PUBLIC DOCUMENT COUNT: 25 FILED AS OF DATE: 20210120 DATE AS OF CHANGE: 20210119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NLS Pharmaceutics Ltd. CENTRAL INDEX KEY: 0001783036 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-236797 FILM NUMBER: 21536592 BUSINESS ADDRESS: STREET 1: ALTER POSTPLATZ 2 CITY: STANS STATE: V8 ZIP: CH-6370 BUSINESS PHONE: 41-79-779-60-00 MAIL ADDRESS: STREET 1: ALTER POSTPLATZ 2 CITY: STANS STATE: V8 ZIP: CH-6370 </SEC-HEADER> <DOCUMENT> <TYPE>F-1/A <SEQUENCE>1 <FILENAME>ea133431-f1a5_nlspharma.htm <DESCRIPTION>AMENDMENT NO. 5 TO FORM F-1 <TEXT> Document 1 - file: ea133431-f1a5_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>ea133431ex1-1_nlspharma.htm <DESCRIPTION>FORM OF UNDERWRITING AGREEMENT BY AND AMONG NLS PHARMACEUTICS LTD. AND THE UNDERWRITERS NAMED THEREIN <TEXT> Document 2 - file: ea133431ex1-1_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.29 <SEQUENCE>3 <FILENAME>ea133431ex10-29_nlspharma.htm <DESCRIPTION>AMENDMENT NUMBER 4 TO CONVERTIBLE LOAN AGREEMENT DATED FEBRUARY 21, 2020 BETWEEN NLS PHARMACEUTICS LTD. AND ALEXANDER ZWYER <TEXT> Document 3 - file: ea133431ex10-29_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.30 <SEQUENCE>4 <FILENAME>ea133431ex10-30_nlspharma.htm <DESCRIPTION>AMENDMENT NUMBER 2 TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND MAGNETIC ROCK INVESTMENT AG <TEXT> Document 4 - file: ea133431ex10-30_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.31 <SEQUENCE>5 <FILENAME>ea133431ex10-31_nlspharma.htm <DESCRIPTION>AMENDMENT NUMBER 3 TO BRIDGE LOAN AGREEMENT BETWEEN NLS PHARMACEUTICS LTD. AND MAGNETIC ROCK INVESTMENT AG <TEXT> Document 5 - file: ea133431ex10-31_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.32 <SEQUENCE>6 <FILENAME>ea133431ex10-32_nlspharma.htm <DESCRIPTION>FORM OF ADDENDUM NUMBER 4 TO PROMISSORY NOTE DATED JANUARY 2019 BETWEEN CERTAIN INVESTORS AND THE COMPANY <TEXT> Document 6 - file: ea133431ex10-32_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.33 <SEQUENCE>7 <FILENAME>ea133431ex10-33_nlspharma.htm <DESCRIPTION>ADDENDUM NUMBER 4 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS PHARMA AG AND THE LENDERS NAMED THEREIN <TEXT> Document 7 - file: ea133431ex10-33_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.34 <SEQUENCE>8 <FILENAME>ea133431ex10-34_nlspharma.htm <DESCRIPTION>ADDENDUM NUMBER 4 TO CREDIT FACILITY DATED AUGUST 31, 2015 BETWEEN NLS-1 PHARMA AG AND THE LENDERS NAMED THEREIN <TEXT> Document 8 - file: ea133431ex10-34_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.35 <SEQUENCE>9 <FILENAME>ea133431ex10-35_nlspharma.htm <DESCRIPTION>ADDENDUM NUMBER 4 TO CONVERTIBLE PROMISSORY NOTE DATED JANUARY 18, 2019 BETWEEN MAGNETIC ROCK INVESTMENT AG AND THE COMPANY <TEXT> Document 9 - file: ea133431ex10-35_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>10 <FILENAME>ea133431ex23-1_nlspharma.htm <DESCRIPTION>CONSENT OF MARCUM LLP <TEXT> Document 10 - file: ea133431ex23-1_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>11 <FILENAME>ea133431ex99-3_nlspharma.htm <DESCRIPTION>REGISTRANT'S REPRESENTATION PURSUANT TO REQUIREMENTS OF FORM 20-F, ITEM 8.A.4 <TEXT> Document 11 - file: ea133431ex99-3_nlspharma.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>12 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 12 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>13 <FILENAME>image_004a.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 13 - file: image_004a.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>14 <FILENAME>image_005.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 14 - file: image_005.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>15 <FILENAME>image_006.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 15 - file: image_006.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>16 <FILENAME>image_007.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 16 - file: image_007.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>17 <FILENAME>image_008.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 17 - file: image_008.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>18 <FILENAME>image_009.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 18 - file: image_009.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>19 <FILENAME>image_010.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 19 - file: image_010.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>20 <FILENAME>image_011.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 20 - file: image_011.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>21 <FILENAME>image_012.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 21 - file: image_012.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>22 <FILENAME>image_013.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 22 - file: image_013.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>23 <FILENAME>image_014.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 23 - file: image_014.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>24 <FILENAME>image_015.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 24 - file: image_015.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>25 <FILENAME>image_016.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 25 - file: image_016.jpg
</DOCUMENT> </SEC-DOCUMENT>